Desmond Curran, Brandon J. Patterson, Justin Carrico, Ahmed Salem, Elizabeth M. La, Stéphane Lorenc, . . . Christopher F. Carpenter. (2023). Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Taylor & Francis Group.
Chicago Style (17th ed.) CitationDesmond Curran, Brandon J. Patterson, Justin Carrico, Ahmed Salem, Elizabeth M. La, Stéphane Lorenc, Katherine A. Hicks, Sara Poston, and Christopher F. Carpenter. Public Health Impact of Recombinant Zoster Vaccine for Prevention of Herpes Zoster in US Adults Immunocompromised Due to Cancer. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationDesmond Curran, et al. Public Health Impact of Recombinant Zoster Vaccine for Prevention of Herpes Zoster in US Adults Immunocompromised Due to Cancer. Taylor & Francis Group, 2023.